Literature DB >> 20824548

Evaluating counseling outcome on adherence to prophylaxis and follow-up after sexual HIV-risk exposure: a randomized controlled trial.

L Bentz1, P Enel, B Dunais, J Durant, I Poizot-Martin, C Tourette-Turgis, M Rebillon, F Le Duff, P Dellamonica, C Pradier.   

Abstract

OBJECTIVE: Post-exposure prophylaxis (PEP) is recommended for the management of sexual HIV-risk exposure. However, a high percentage of exposed patients discontinue both their 28-day prophylaxis course before 15 days and HIV testing follow-up before M3. The objective of this study is to assess the efficacy of a counseling intervention in enhancing both adherence to PEP and HIV testing follow-up.
METHODS: Between 1 June 2004 and 31 December 2005, 54 patients exposed to sexual HIV-risk exposure were included in a multicenter, prospective, controlled, randomized trial, comparing a group receiving a counseling intervention in addition to traditional medical management (intervention group (IG), n=28) vs. a control group (CG, n=26). Patients in the IG received interactive counseling interventions focused on adherence to PEP and to HIV testing follow-up, led by specially trained nurses. The main outcome measures were proportion of patients achieving 100% adherence to PEP as evaluated on D15 by a self-completed patient questionnaire and on HIV testing on D45 and M3.
RESULTS: Groups were well balanced at baseline for age, sex, and circumstances of exposure. The proportion of 100% adherent patients to PEP was significantly higher in the IG compared to the CG (54% vs. 23%, p=0.036). Patients in the IG were more likely to complete the HIV testing follow-up at D45 (86% vs. 54%, p=0.023) and M3 (68% vs. 38%, p=0.056).
CONCLUSIONS: This study suggests the effectiveness of a counseling program to enhance adherence to both PEP and HIV testing follow-up after sexual exposure.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20824548     DOI: 10.1080/09540121.2010.484457

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  8 in total

1.  Optimizing adherence to preexposure and postexposure prophylaxis: the need for an integrated biobehavioral approach.

Authors:  Aaron J Blashill; Peter P Ehlinger; Kenneth H Mayer; Steven A Safren
Journal:  Clin Infect Dis       Date:  2015-06-01       Impact factor: 9.079

2.  High Levels of Concomitant Behavioral Health Disorders Among Patients Presenting for HIV Non-occupational Post-exposure Prophylaxis at a Boston Community Health Center Between 1997 and 2013.

Authors:  Sachin Jain; Catherine E Oldenburg; Matthew J Mimiaga; Kenneth H Mayer
Journal:  AIDS Behav       Date:  2016-07

Review 3.  Preparing for HIV pre-exposure prophylaxis: lessons learned from post-exposure prophylaxis.

Authors:  Stephanie E Cohen; Albert Y Liu; Kyle T Bernstein; Susan Philip
Journal:  Am J Prev Med       Date:  2013-01       Impact factor: 5.043

Review 4.  Adherence to post-exposure prophylaxis for non-forcible sexual exposure to HIV: a systematic review and meta-analysis.

Authors:  Catherine E Oldenburg; Till Bärnighausen; Guy Harling; Matthew J Mimiaga; Kenneth H Mayer
Journal:  AIDS Behav       Date:  2014-02

5.  Current status of medication adherence and infant follow up in the prevention of mother to child HIV transmission programme in Addis Ababa: a cohort study.

Authors:  Alemnesh H Mirkuzie; Sven Gudmund Hinderaker; Mitike Molla Sisay; Karen Marie Moland; Odd Mørkve
Journal:  J Int AIDS Soc       Date:  2011-10-21       Impact factor: 5.396

6.  Predictors of Standard Follow-Up Completion after Sexual Exposure to HIV: Five-Year Retrospective Analysis in a French HIV-Infection Care Center.

Authors:  Pierre Gantner; Michele Treger; Constance De Miscault; Marie-Laure Batard; Claudine Bernard-Henry; Christine Cheneau; Erik De Mautort; Marialuisa Partisani; Michele Priester; David Rey
Journal:  PLoS One       Date:  2015-12-22       Impact factor: 3.240

7.  Evaluation of tolerability with the co-formulation elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate for post-HIV exposure prophylaxis.

Authors:  Nadia Valin; Laurent Fonquernie; Anne Daguenel; Pauline Campa; Theresita Anthony; Marguerite Guiguet; Pierre Marie Girard; Marie Caroline Meyohas
Journal:  BMC Infect Dis       Date:  2016-11-29       Impact factor: 3.090

8.  Pre-exposure and postexposure prophylaxes and the combination HIV prevention methods (The Combine! Study): protocol for a pragmatic clinical trial at public healthcare clinics in Brazil.

Authors:  Alexandre Grangeiro; Márcia Thereza Couto; Maria Fernanda Peres; Olinda Luiz; Eliana Miura Zucchi; Euclides Ayres de Castilho; Denize Lotufo Estevam; Rosa Alencar; Karina Wolffenbüttel; Maria Mercedes Escuder; Gabriela Calazans; Dulce Ferraz; Érico Arruda; Maria da Gloria Corrêa; Fabiana Rezende Amaral; Juliane Cardoso Villela Santos; Vivian Salles Alvarez; Tiago Kietzmann
Journal:  BMJ Open       Date:  2015-08-25       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.